Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals, today announced participation at the following upcoming conferences:
World Biofuels Markets BrazilDate: Tuesday, September 18Time: 4:20 p.m. BRTLocation: Grand Hyatt Sao Paulo in Sao Paulo, BrazilSpeaker: David Anton, Senior Vice President, Bioindustrials
Credit Suisse 3 rd Annual Small & Mid Cap ConferenceDate: Thursday, September 20Time: 8:00 a.m. EDTLocation: New York Palace Hotel in New York, NYSpeaker: John Nicols, President and Chief Executive Officer
About Codexis, Inc.Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals. Codexis’ product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent alcohol. Partners and customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts